GA2

9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE

GA2 is found in 2 entries

GA2 as free ligands, exist in 2 entries. Examples include 1KI2, 4DA6,

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Name 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE
Identifiers 2-amino-9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}-1,9-dihydro-6H-purin-6-one
2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one
Formula C9 H13 N5 O4
Molecular Weight 255.23 g/mol
Type non-polymer
Isomeric SMILES Nc1nc2n(COC(CO)CO)cnc2c(=O)[nH]1
InChI InChI=1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17)
InChI Key IRSCQMHQWWYFCW-UHFFFAOYSA-N

Chemical Details

Formal Charge 0
Atom Count 31
Chiral Atom Count 0
Chiral Atoms
Bond Count 32
Aromatic Bond Count 5

Drug Info: DrugBank

DrugBank ID DB01004   (Stereoisomeric match)
Name Ganciclovir
Groups
  • approved
  • investigational
Description An acyclovir analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. [PubChem]
Synonyms
  • 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol
  • 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one
  • 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one
  • 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol
  • 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one
  • 2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone
  • 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine
  • 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine
  • GA2
  • Ganciclovir
  • Ganciclovirum
  • Gancyclovir
[more]
Salts Ganciclovir Sodium
Brand Names
  • Cytovene - Cap 250mg
  • Cytovene - Pws 500mg/10m/-vial IV
  • Cytovene IV
  • Cytovene Inj 500mg/vial
  • Cytovene, 500 mg
  • Ganciclovir
  • Ganciclovir for Injection
  • Vitrasert, Intravitreal Implant
  • Zirgan
  • Cytovene
  • Vitrasert
[more]
Affected Organism Human Herpes Virus
Indication For induction and maintenance in the treatment of cytomegalovirus (CMV) retinitis in immunocompromised patients, including patients with acquired immunodeficiency syndrome (AIDS). Also used in the treatment of severe cytomegalovirus (CMV) disease, including CMV pneumonia, CMV gastrointestinal disease, and disseminated CMV infections, in immunocompromised patients.
Pharmacology Ganciclovir is a synthetic nucleoside analogue of 2'-deoxyguanosine that inhibits replication of herpes viruses both in vitro and in vivo. Sensitive human viruses include cytomegalovirus (CMV), herpes simplex virus -1 and -2 (HSV-1, HSV-2), Epstein-Barr virus (EBV) and varicella zoster virus (VZV), however clinical studies have been limited to assessment of efficacy in patients with CMV infection. Ganciclovir is a prodrug that is structurally similar to acyclovir. It inhibits virus replication by its encorporation into viral DNA. This encorporation inhibits dATP and leads to defective DNA, ceasing or retarding the viral machinery required to spread the virus to other cells.
Mechanism of action Ganciclovir's antiviral activity inhibits virus replication. This inhibitory action is highly selective as the drug must be converted to the active form by a virus-encoded cellular enzyme, thymidine kinase (TK). TK catalyzes phosphorylation of ganciclovir to the monophosphate, which is then subsequently converted into the diphosphate by cellular guanylate kinase and into the triphosphate by a number of cellular enzymes. In vitro, ganciclovir triphosphate stops replication of herpes viral DNA. When used as a substrate for viral DNA polymerase, ganciclovir triphosphate competitively inhibits dATP leading to the formation of 'faulty' DNA. This is where ganciclovir triphosphate is incorporated into the DNA strand replacing many of the adenosine bases. This results in the prevention of DNA synthesis, as phosphodiester bridges can longer to be built, destabilizing the strand. Ganciclovir inhibits viral DNA polymerases more effectively than it does cellular polymerase, and chain elongation resumes when ganciclovir is removed.
Route of administration
  • intravenous
  • intravitreal
  • ophthalmic
  • oral
Categories
  • Antiviral Agents
  • ["D27.505.954.122.388"]
ATC-Code
  • J05AB06
  • S01AD09
AHFS-Code 08:18.32
CAS number 82410-32-0
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682